Andrew Cooper
Stock Analyst at Raymond James
(3.37)
# 1,011
Out of 5,113 analysts
151
Total ratings
49.25%
Success rate
3.41%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Outperform | $35 → $45 | $39.03 | +15.30% | 3 | Nov 25, 2025 | |
| ITGR Integer Holdings | Reiterates: Outperform | $143 → $95 | $85.90 | +10.59% | 4 | Oct 24, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | n/a | $75.10 | - | 13 | Oct 22, 2025 | |
| AVTR Avantor | Maintains: Outperform | $14 → $16 | $11.05 | +44.80% | 16 | Oct 16, 2025 | |
| HAE Haemonetics | Downgrades: Outperform | $105 → $78 | $66.06 | +18.07% | 10 | Aug 11, 2025 | |
| GH Guardant Health | Maintains: Outperform | $59 → $61 | $109.73 | -44.41% | 4 | Jul 31, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $120 → $115 | $111.13 | +3.48% | 9 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $525 → $535 | $608.02 | -12.01% | 7 | Jul 24, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $5.72 | +74.83% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $26.40 | -5.30% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $243.90 | - | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $224.54 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $102.25 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.46 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $235.93 | -63.97% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $26.79 | +183.69% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $5.12 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.38 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $38.48 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.70 | - | 5 | Sep 22, 2021 |
Azenta
Nov 25, 2025
Maintains: Outperform
Price Target: $35 → $45
Current: $39.03
Upside: +15.30%
Integer Holdings
Oct 24, 2025
Reiterates: Outperform
Price Target: $143 → $95
Current: $85.90
Upside: +10.59%
Hologic
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $75.10
Upside: -
Avantor
Oct 16, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $11.05
Upside: +44.80%
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105 → $78
Current: $66.06
Upside: +18.07%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $109.73
Upside: -44.41%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120 → $115
Current: $111.13
Upside: +3.48%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525 → $535
Current: $608.02
Upside: -12.01%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $5.72
Upside: +74.83%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $26.40
Upside: -5.30%
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $243.90
Upside: -
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $224.54
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $102.25
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $20.46
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $235.93
Upside: -63.97%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $26.79
Upside: +183.69%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $5.12
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $12.38
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $38.48
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $2.70
Upside: -